AIDS Newswire
1 - SeraCare Life Sciences Awarded Multiple Contracts from the CDC and NIH to Support HIV Research and the Accuracy of HIV Testing
MILFORD, Mass.-(Business Wire)-September 29, 2009 - SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been...
2 - ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections
LUXEMBOURG & MELBOURNE, Australia-(Business Wire)-September 29, 2009 - ABL, S.A. and Evivar Medical Pty Ltd today announced the completion of agreements to cross-licence their respective intellectual property portfolios and to form strategic alliances based on the use of their proprietary...
3 - Computable Genomix Announces Contest For Genomics Researchers
MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...
4 - San Francisco, Sept. 30th: Grand Opening of New AHF “Magic Johnson” HIV/AIDS Clinic on Church St.
SAN FRANCISCO-(Business Wire)-September 28, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the grand opening of the...
5 - Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology
GENEVA-(Business Wire)-September 28, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million...
6 - Calypte Biomedical Announces Changes to its Board of Directors
PORTLAND, Ore.-(Business Wire)-September 25, 2009 - Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announces changes to its board of directors. On September 16, 2009, Calypte reported that Julius R. Krevans, M.D., John J. DiPietro and...
7 - pSivida Corp. Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2009
WATERTOWN, Mass.-(Business Wire)-September 24, 2009 - pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) (FF: PV3), a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back of the eye diseases, today announced financial...
8 - Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 24, 2009 - Global Solutions for Infectious Diseases (“GSID”) announced today that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The...
9 - The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine
-(Business Wire)-September 24, 2009 - MEDIA ADVISORY: WHAT: International Symposium “Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV.” More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an...
10 - IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand
NEW YORK-(Business Wire)-September 24, 2009 - The International AIDS Vaccine Initiative (IAVI) greeted with excitement today’s announcement by the U.S. Military HIV Research Program and the Thai Ministry of Public Health that, according to an initial analysis, a prime-boost combination of two AIDS...
11 - Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities
BOSTON-(Business Wire)-September 23, 2009 - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental...
12 - AHF’s Blair Underwood HIV/AIDS Clinic to Open in DC Thursday Sept. 24th
WASHINGTON-(Business Wire)-September 23, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening...
13 - ARISE Magazine is Proud to Announce Sponsorship Commitment to Alicia Keys’ 2009 Keep a Child Alive Black Ball
NEW YORK-(Business Wire)-September 22, 2009 - Keep a Child Alive's (KCA) 2009 Black Ball, an annual benefit to raise funds dedicated to providing life-saving treatment and support to children and families affected by HIV/AIDS, is proud to announce ARISE Magazine as a confirmed sponsor. ARISE...
14 - Academy of Friends Selects Eleven Bay Area HIV/AIDS Organizations as 2010 Gala Beneficiaries
SAN FRANCISCO-(Business Wire)-September 22, 2009 - Academy of Friends proudly announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations. Known for its annual Academy Awards® Night Charity Gala and monthly social events, AOF raised more than $7.5 million benefitting over...
15 - AIDS Healthcare Foundation’s First ‘AHF Blair Underwood Healthcare Center’ to Open in DC
WASHINGTON-(Business Wire)-September 21, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening...
16 - Sloning Closes Growth Financing Round Led by LBBW Venture
PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...
17 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis
BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...
18 - NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies
WEST HAVEN, Conn.-(Business Wire)-September 21, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established...
19 - MyInsuranceExpert Supports Local Aids Walk in Effort to Increase Healthy Living Awareness
TROY, Mich.-(Business Wire)-September 18, 2009 - My Insurance Expert, one of the nation leading online services to compare and secure affordable health insurance, is supporting AIDS Walk Detroit 2009 with a corporate donation and encouraging employees and friends to participate in the annual...
20 - Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program
GREEN BAY, Wis.-(Business Wire)-September 18, 2009 - Integrative Therapeutics, Inc (ITI®), in collaboration with the American Association of Naturopathic Physicians (AANP), is seeking qualified residency sites for the fourth year of the ITI & AANP STAIRSM Residency Scholarship Program. This...
21 - The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine
-(Business Wire)-September 18, 2009 - MEDIA ADVISORY: WHAT: International Symposium “Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV.” More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an...
22 - Hythiam Raises Approximately $7 Million in Registered Direct Offering
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...
23 - AHF Hosts Grand Opening of 1st Oakland “Out of the Closet”—the World’s Most Fabulous Thrift Store
OAKLAND, Calif.-(Business Wire)-September 17, 2009 - AIDS Healthcare Foundation (AHF): What: Grand Opening/Ribbon-Cutting Ceremony ‘Out of the Closet’ – the World’s Most Fabulous Thrift Store When: Saturday, September 19th 10:00 a.m. (Store Open: 10:00 a.m. to 7:00...
24 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets
WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...
25 - Inovio Biomedical CEO to Present at MIT Technology Review Emerging Technology Conference
SAN DIEGO-(Business Wire)-September 16, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and...
26 - Cytheris Announces Interim Data from INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIV-Infected Patients
PARIS-(Business Wire)-September 15, 2009 - Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced presentation of data from an interim analysis of CLI-107-06 (INSPIRE), a Phase I/IIa study of HIV-infected...
27 - NanoViricides Platform Enables Rapid Development of Robust Nanomedicines Against Influenza and HIV
WEST HAVEN, Conn.-(Business Wire)-September 14, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company presented a talk at NanoBusiness 2009 - the 8th annual NanoBusiness Conference in Chicago, IL, on Wednesday, September 9th. Dr...
28 - Merck's ISENTRESS® (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naïve Patients
SAN FRANCISCO-(Business Wire)-September 13, 2009 - ISENTRESS® , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated...
29 - CA Legislature Passes Streamlined Rapid HIV Testing Bill; AHF Urges Schwarzenegger to Sign Common Sense Law
SACRAMENTO, Calif.-(Business Wire)-September 12, 2009 - AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised the California Legislature for its passage of Assembly Bill 221, which cleared the Assembly on final concurrence...
30 - Research and Markets: Disease and Therapy Review: a Comprehensive Overview of HIV/AIDS and Related Conditions
DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets III. Diagnosis And Treatment Diagnostic Tests Antiretroviral Treatments IV. Dosing And Treatment Costs V. Market Size VI. Comments VII. References/Resources For more information visit...
31 - LabCorp is Scheduled to Present at the UBS 2009 Global Life Sciences Conference
BURLINGTON, N.C.-(Business Wire)-September 11, 2009 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the UBS 2009 Global Life Sciences Conference in New York City, NY. LabCorp’s...
32 - New WHO Data Underscores Global Threat of the World’s Leading Child Killer
WASHINGTON-(Business Wire)-September 11, 2009 - New World Health Organization data to be published in this week's edition of The Lancet will shed new light on two leading causes of pneumonia, the world’s leading killer of children under age 5, both globally and within specific countries. The...
33 - E-18 Corp. Announces Availability of a White Paper by SmallcapInsights.com
MINNEAPOLIS-(Business Wire)-September 10, 2009 - E-18 Corp. (OTCBB:ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a white paper on the global market for safety syringes...
34 - Warner Bros. Consumer Products Announces Highly Anticipated Online Auction for World-Renowned Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection in Celebration of the 70th Anniversary of The Wizard of Oz
BURBANK, Calif.-(Business Wire)-September 10, 2009 - Warner Bros. Consumer Products today announced the opening of the highly anticipated online auction for The Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection, beginning September 10 at 10:00 a.m. EDT at...
35 - HIV Screening Tests Proposed to Be Added to Medicare’s List of Covered Preventive Services
WASHINGTON-(Business Wire)-September 9, 2009 - The Department of Health and Human Services (HHS) today announced a new proposal that would cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are...
36 - St. Vincent’s, State Health Department Unveil Novel Technology to Fight Spread of HIV
NEW YORK-(Business Wire)-September 9, 2009 - Saint Vincent Catholic Medical Centers and the New York State Department of Health (DOH) today unveiled a novel Web-based technology to rapidly instruct health care providers throughout New York State about HIV diagnosis and prevention. Developed by a...
37 - Over One Third of All Oral and Throat Cancers Are Due to Sexual Practices
BEVERLY HILLS, Calif.-(Business Wire)-September 9, 2009 - Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower Cancer...
38 - Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers
MOUNTAIN VIEW, Calif.-(Business Wire)-September 9, 2009 - Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009. Considering that fewer than 20 genomes have been...
39 - Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs
NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Mohan Chellani, Ph.D., formerly a senior manager with Quest Diagnostics, as Vice President of Scientific Affairs at its Enzo Clinical Labs subsidiary. He will oversee all aspects of the...
40 - LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference
BURLINGTON, N.C.-(Business Wire)-September 8, 2009 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare Conference in London, United...
41 - Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference
NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...
42 - IAVI: Two New Antibodies Found to Cripple HIV
NEW YORK & LA JOLLA & SAN FRANCISCO, Calif. & SEATTLE-(Business Wire)-September 3, 2009 - Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram...
43 - Illumina to Present at Upcoming Investment Conferences in September
SAN DIEGO-(Business Wire)-September 3, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at three upcoming investment conferences. Illumina will webcast its presentation at the Thomas Weisel Partners Healthcare Conference in Boston, Massachusetts...
44 - AHF Challenges Merck’s “Criminal AIDS Drug Pricing” for Isentress
WASHINGTON-(Business Wire)-September 3, 2009 - As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today unveiled its latest advocacy campaign challenging Merck and Co. Pharmaceuticals over the steep price of its key HIV/AIDS drug, Isentress...
45 - Enabling Capabilities of Inovio Biomedical’s Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute
SAN DIEGO-(Business Wire)-September 3, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that data generated from a pre-clinical collaborative study by National Cancer Institute (NCI) and Inovio scientists were published...
46 - AHF: Pfizer Wrongdoing Echoes Viagra Case
WASHINGTON-(Business Wire)-September 2, 2009 - As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today lauded the U.S. Justice Department’s crackdown on Pfizer, Inc. for its fraudulent drug marketing practices. It was reported today that...
47 - E-18 Corp. Announces Availability of SmallcapInsights.com Article
MINNEAPOLIS-(Business Wire)-September 1, 2009 - E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a SmallcapInsights.com article by industry veteran, Dr...
48 - WTN Services(R) and the Winetasting Network(R) Take Lead in Philanthropic Effort
NAPA, Calif.-(Business Wire)-August 27, 2009 - WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community. WTN Services(R) and the...
49 - AIDS Healthcare Foundation Mourns Kennedy as “Champion of People without a Voice”
WASHINGTON-(Business Wire)-August 26, 2009 - AIDS Healthcare Foundation (AHF), the nation’s largest non-profit HIV/AIDS healthcare provider which now provides treatment and services for more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia...
50 - Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain
PLANTATION, Fla.-(Business Wire)-August 26, 2009 - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants...
51 - Novelos Therapeutics Announces $9 Million Private Placement
NEWTON, Mass.-(Business Wire)-August 26, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing...
52 - AHF: L.A. County Says Impact of Thousands of Infections in Porn Industry, “Minimal”
LOS ANGELES-(Business Wire)-August 25, 2009 - AIDS Healthcare Foundation: “In its petition, AHF is requesting that the County take action within the adult film industry only. As set forth in the petition, the adult film industry employs approximately 1,200 adult film performers at any given...
53 - Profectus BioSciences Enters into Research Collaboration Agreement with the PATH Malaria Vaccine Initiative (MVI)
BALTIMORE-(Business Wire)-August 25, 2009 - Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the...
54 - HHS Secretary Sebelius Announces Intent to Appoint Dr. Helene Gayle as Chair of the Presidential Advisory Council on HIV/AIDS at 2009 National HIV Prevention Conference
WASHINGTON-(Business Wire)-August 24, 2009 - Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the...
55 - BioAlliance Pharma: Loramyc® Obtains Marketing Authorization in Switzerland
Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that Loramyc® has obtained Marketing Authorization in Switzerland for the treatment of oropharyngeal candidiasis in immunocompromised patients...
56 - Novelos Therapeutics Completes Warrant Tender
NEWTON, Mass.-(Business Wire)-August 24, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos issued approximately 2,100,000 shares of its Common Stock to certain holders of...
57 - Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study
BOCA RATON, Fla.-(Business Wire)-February 17, 2009 - Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, in...
58 - 454 Sequencing Identifies Early Stage HIV Drug Resistance-- Low-level Mutations may have Significant Impact on Clinical Outcomes
BRANFORD, Conn-(Business Wire)-February 17, 2009 - A research study published online this week in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a significant impact on clinical outcomes. The paper outlines the...
59 - FOX Rejects PG-rated AHF Condom Ad during Raunchy ‘Family Guy’
LOS ANGELES-(Business Wire)-February 13, 2009 - AIDS Healthcare Foundation (AHF): DAY: What: Press Conference & Teleconference LA FOX Affiliate Bans Condom Ad from ‘Family Guy’ Program When: Friday, FEBRUARY 13TH 12:00NOON PACIFIC TIME Where: AIDS Healthcare...
60 - LabCorp is the First National Commercial Lab to Offer Roche’s COBAS® AmpliPrep/COBAS® TaqMan® HCV Test
BURLINGTON, N.C.-(Business Wire)-February 12, 2009 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV Test. This...
61 - AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+
LOS ANGELES-(Business Wire)-February 12, 2009 - A groundbreaking global effort led by AIDS Healthcare Foundation (AHF) to test one million people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more...
62 - Panacos Announces Additional Personnel Departures
WATERTOWN, Mass.-(Business Wire)-February 11, 2009 - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), today announced the Company’s Chief Medical Officer, Scott McCallister, and the Vice President of Manufacturing Operations, John Richards, will leave Panacos on February 13, 2009. These positions...
63 - Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan
NEWTON, Mass.-(Business Wire)-February 11, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced today that Novelos signed an exclusive collaboration agreement with Mundipharma International...
64 - OraSure Announces Fourth Quarter and Full Year 2008 Financial Results
BETHLEHEM, Pa.-(Business Wire)-February 11, 2009 - OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $71.1 million and $17.2 million for the year and quarter ended December 31, 2008, respectively. This compares to revenues of $82.7...
65 - NERI to Launch First Multi-National Observational Registry for Men Diagnosed with Testosterone Deficiency
WATERTOWN, Mass.-(Business Wire)-February 11, 2009 - New England Research Institutes, Inc. (NERI), is developing and launching a large, multi-national observational (non-intervention) registry for men with testosterone deficiency, a condition also known as hypogonadism (HG) or androgen deficiency...
66 - BioAlliance Pharma: 2008 Consolidated Turnover: +134%
Regulatory News: BioAlliance Pharma SA (Euronext Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced a 2008 turnover of €8.2 million, strongly increased from €3.5 million in 2007. (amounts in millions of euros...
67 - AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+
LOS ANGELES-(Business Wire)-February 10, 2009 - A groundbreaking global effort led by AIDS Healthcare Foundation (AHF) to test one million people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more...
68 - Research and Markets: Good Prospects of Finding a Cure for HIV/AIDS in The Next Decade Reveals Report
DUBLIN, Ireland-(Business Wire)-February 10, 2009 - Research and Markets . There a number of treatments but HSV is not destroyed completely and remains dormant and activates from time to time to cause various clinical manifestations. There is discussion about the role of HPV in cervical cancer and...
69 - Data from ISENTRESS®, Merck's HIV Integrase Inhibitor, in Patients Whose HIV is Controlled on a Lopinavir/Ritonavir-Based Therapy Presented at the 16th Conference on Retroviruses and Opportunistic Infections
MONTREAL-(Business Wire)-February 9, 2009 - Merck & Co., Inc. (NYSE: MRK): Switching from Lopinavir/Ritonavir-Based to ISENTRESS-Based Combination Antiretroviral Therapy Significantly Improved Total Cholesterol, Triglycerides, Non-HDL-Cholesterol at Week 12 Switching from...
70 - Phase III Studies Showed ISENTRESS® in Combination Therapy Provided Significant Viral Load Reductions through 96 Weeks in Treatment-Experienced Patients with Triple-Class Resistant HIV
MONTREAL-(Business Wire)-February 9, 2009 - In new subgroup analyses of a Phase III study (STARTMRK) that compared Merck & Co., Inc.'s integrase inhibitor ISENTRESS® (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated (treatment-naïve...
71 - Gilead Announces Data Demonstrating Pharmacokinetic Boosting Activity of GS 9350
MONTREAL-(Business Wire)-February 9, 2009 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced preclinical data and results from two Phase I studies for GS 9350, an investigational compound being developed as a pharmacoenhancing agent (“booster”) to increase blood levels and allow once-daily...
72 - Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System
OAKLAND, Calif.-(Business Wire)-February 9, 2009 - Ramsell Public Health Rx, a pharmacy benefit manager and information management company, today announced the availability of the AIDS Drug Assistance Program (ADAP) Data Management System, a highly configurable, web-based system designed to assist...
73 - Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI)
Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announces the presentation of its results on a new quinoline family acting as HIV integrase inhibitors at the 16th Conference on...
74 - Health Management Associates, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call and Webcast
NAPLES, Fla.-(Business Wire)-February 6, 2009 - Health Management Associates, Inc. (NYSE:HMA) announced today that on February 23, 2009 it will report results for its fourth quarter and year ended December 31, 2008. HMA will issue a press release after the market closes on Monday, February 23, 2009...
75 - The Genome Center at Washington University Scales-Up on Illumina Sequencers
SAN DIEGO-(Business Wire)-February 6, 2009 - Illumina, Inc. (NASDAQ:ILMN) announced today that it has reached an agreement in principle for the Genome Center at Washington University School of Medicine in St. Louis to acquire 21 genome analyzers over the next several months to support the Center’s...
76 - Progen-Avexa Merger Notice of Meeting and Independent Expert Report
BRISBANE, Australia-(Business Wire)-February 5, 2009 - The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) today released the Notice of Meeting regarding the Avexa merger and share buy back and confirmed their unanimous recommendation for the proposed merger with...
77 - Avexa Announces Release of the Independent Expert Report
MELBOURNE, Australia-(Business Wire)-February 5, 2009 - Avexa Limited (ASX:AVX) today released the Independent Expert’s Report prepared by Lonergan Edwards & Associates Limited. The report was commissioned for the purposes of Avexa shareholders’ assessment of the proposed merger of Avexa and...
78 - March 15th: Actor, Activist Blair Underwood to Join Thousands for Florida AIDS Walk 2009
FT. LAUDERDALE, Fla.-(Business Wire)-February 5, 2009 - AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, March 15, 2009 Opening Ceremony: 9:15 am, Walk Begins: 10:00 a.m. Where: Huizenga Plaza, Downtown Ft. Lauderdale Who: Blair Underwood, actor (Dirty Sexy Money...
79 - Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc.
NEW YORK-(Business Wire)-February 5, 2009 - Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on GeoVax Labs, Inc. GeoVax Labs, Inc. (BB:GOVX), is a biotechnology company developing human vaccines for diseases caused by HIV-1 and other infectious agents...
80 - Illumina Presents Development Roadmap for Scaling its Genome Analyzer
SAN DIEGO-(Business Wire)-February 5, 2009 - Illumina, Inc. (NASDAQ:ILMN) unveiled a development roadmap for its Genome Analyzer system that charts a path to generate greater than 95 Gigabases of high quality data per run in 2009. This roadmap, which was presented at a user-group meeting at this...
81 - MEDNAX Earns 81 Cents, non-GAAP, in 2008 Fourth Quarter
FORT LAUDERDALE, Fla.-(Business Wire)-February 5, 2009 - MEDNAX, Inc. (NYSE:MD), the national medical group providing newborn, maternal-fetal, pediatric subspecialty and anesthesia physician services, today reported earnings per share of 85 cents for the 2008 fourth quarter, or 81 cents on a...
82 - Research and Markets: Iran Pharmaceuticals and Healthcare Report Q1 2009 - In the Past Five Years Iran's Authorities Spent Around US$20mn on HIV/AIDS Control and Education
DUBLIN, Ireland-(Business Wire)-February 4, 2009 - Research and Markets in October 2008. There is a growing risk that social stability could be compromised by the government's seeming inability to control inflation. As the increase is commodity costs is passed on to consumers, pharmaceutical...
83 - Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material
ROCKVILLE, Md.-(Business Wire)-February 4, 2009 - Omnia Biologics, Inc. (Rockville, MD) and Sumagen Co., Ltd. (London, ON) today jointly announced the successful completion of cGMP manufacture of Sumagen’s HIV/AIDS vaccine for a Phase I clinical trial. Safe, effective vaccines for HIV...
84 - MEDNAX, Inc. Acquires Neonatal Practice
FORT LAUDERDALE, Fla.-(Business Wire)-February 4, 2009 - MEDNAX, Inc. (NYSE:MD) today announced that it has completed the acquisition of a neonatal group based in Arlington, Texas. Arlington Neonatal Intensive Care, P.A., is a two-physician practice that staffs the Level III neonatal intensive...
85 - Aethlon Medical Provides Clinical Update at International Conference on Dialysis
SAN DIEGO-(Business Wire)-February 3, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chief Science Officer, Dr. Richard H. Tullis presented a clinical report on the Aethlon Hemopurifier® to Nephrologists attending the International Conference on Dialysis on January 29th. The...
86 - Affymax to Present at BIO CEO and Investor Conference
PALO ALTO, Calif.-(Business Wire)-February 3, 2009 - Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, president and chief executive officer, will present at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 2:15 p.m. ET at the Waldorf Astoria in New...
87 - AHF: Senate Democrats Allow HIV Testing To Be Stripped From Stimulus
WASHINGTON-(Business Wire)-February 3, 2009 - AIDS Healthcare Foundation (AHF), the nation’s largest AIDS organization, expressed its disappointment that Senate Democratic leaders agreed to remove a provision from the stimulus bill allocating $400 million for prevention of sexually transmitted...
88 - Gilead Announces Senior Management Promotion
FOSTER CITY, Calif.-(Business Wire)-February 2, 2009 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced the promotion of Andrew Cheng, MD, PhD to the newly created role of Senior Vice President, Development Operations. In this role, Dr. Cheng will be responsible for Gilead’s biometrics...
89 - Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery
DRESDEN, Germany-(Business Wire)-February 2, 2009 - Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that it has signed a research agreement to support Boehringer Ingelheim in its ongoing efforts to discover novel therapeutic drug...
90 - ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation
CHELMSFORD, Mass.-(Business Wire)-January 30, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS) and Alsius Medical Corporation in the Central...
91 - Progen-Avexa Merger Update
BRISBANE, Australia-(Business Wire)-January 30, 2009 - The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) confirm their unanimous recommendation for the proposed merger with Avexa Limited (“Avexa”) (ASX:AVX). The board believes that the current merger proposal...
92 - AHF Applauds Senator Harkin for Championing HIV Testing in Stimulus Bill
WASHINGTON-(Business Wire)-January 30, 2009 - AIDS Healthcare Foundation (AHF), the nation’s largest AIDS organization, today lauded Senator Tom Harkin (D, IA) for championing the funding of HIV testing in the current Senate stimulus bill. The Senate bill allocates $400 million of the over $800...
93 - AHF: Abbott Censors AIDS Activists on YouTube?
LOS ANGELES-(Business Wire)-January 29, 2009 - A video parody criticizing Abbott Laboratories Inc. for its AIDS drug pricing mysteriously disappeared from YouTube today after 36 hours and 902 views. Parody: AHF Slams Abbott AIDS Drug Pricing, includes the PETA commercial recently banned from...
94 - Photo of AIDS Healthcare Foundation Advocates and Chicago-Area Activists Protesting Abbott Laboratories' AIDS Drug Prices in Mexico and Colombia is Available on Business Wire's Web Site and AP PhotoExpress
CHICAGO-(Business Wire)-January 28, 2009 - AIDS Healthcare Foundation advocates, joined by Chicago-area medical student activists and the Chicago Women's AIDS Project, protested today outside the Lake Forest, IL home of Abbott Laboratories' CEO Miles D. White over the company's AIDS drug prices in...
95 - Orlando-based Health Initiative Wins National Award for HIV Prevention and Continuum of Care to Individuals
PHOENIX-(Business Wire)-January 28, 2009 - Orlando Health has been honored by the Premier healthcare alliance with the 17th Annual Monroe E. Trout Premier Cares Award for its Help Understand and Guide Me (HUG-Me) program, which provides comprehensive HIV care to individuals in Central Florida...
96 - Join the Twin Cities Oscar Night® America Party to Benefit the Minnesota AIDS Project
MINNEAPOLIS-(Business Wire)-January 28, 2009 - The excitement and glamour of Hollywood are coming to Minneapolis on Oscar Night. Twin Cities residents can experience the thrills and surprises of the 81st Academy Awards® on Sunday, February 22, 2009, at Minnesota’s own Oscar Night America party...
97 - Abbott Drug Pricing Condemned by AIDS Advocates in International Protests
CHICAGO-(Business Wire)-January 28, 2009 - As part of an ongoing multinational campaign to lower drug prices and improve access to lifesaving AIDS treatments globally, AIDS advocates from three countries—Colombia, Mexico and the United States—are holding simultaneous protests today in each of...
98 - IVAX Diagnostics Announces Appointment of Charles R. Struby as Chief Executive Officer and President
MIAMI-(Business Wire)-January 27, 2009 - IVAX Diagnostics, Inc. (AMEX:IVD) announced today that Charles R. Struby, Ph.D., has been appointed its Chief Executive Officer and President following the resignation of its prior Chief Executive Officer and President, Paul F. Kennedy, who resigned from such...
99 - AHF Welcomes Mexico’s Dr. Jorge Saavedra as Its New Chief of Global Affairs
LOS ANGELES-(Business Wire)-January 27, 2009 - AIDS Healthcare Foundation (AHF) is pleased to announce that Jorge Saavedra, MD, MPH, MHPM, has joined the AHF leadership team as its new Chief of Global Affairs. Dr. Saavedra brings to the position a breadth of knowledge and experience as an HIV/AIDS...
100 - Altarum Acquires KAI Research, Inc.
ANN ARBOR, Mich.-(Business Wire)-January 27, 2009 - Altarum Institute President and CEO Lincoln Smith announced today that Altarum has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI will become a for-profit, wholly-owned subsidiary and will continue to operate from its current...
101 - Bill Gates Publishes First Annual Letter
SEATTLE-(Business Wire)-January 26, 2009 - Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his first Annual Letter on the work of the foundation—a candid and personal appraisal of the foundation’s efforts to date that also identifies his priorities for the future...
102 - Aethlon Medical Completes First Medical Device Study to Treat HIV/AIDS
SAN DIEGO-(Business Wire)-January 26, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has completed the “first-in-man” study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, an...
103 - IAVI and Algonomics to Collaborate on HIV Protein Design Project
GENT, Belgium & NEW YORK-(Business Wire)-January 26, 2009 - The International AIDS Vaccine Initiative (IAVI) and Algonomics today announced a collaboration to modify an HIV protein in order to improve immune responses elicited by HIV vaccine candidates that include the protein as an insert...
104 - Obama Lifts Global Funding Ban, Unties Hands of HIV/AIDS Groups, Says AHF
WASHINGTON-(Business Wire)-January 24, 2009 - AIDS Healthcare Foundation (AHF) today lauded President Barack Obama for lifting a ban on federal funds for international groups that perform abortions or provide information or counseling on the option. According to the Associated Press, “The policy...
105 - VIRxSYS to Present at Phacilitate Cell & Gene Therapy Forum
-(Business Wire)-January 22, 2009 - VIRxSYS WHAT: VIRxSYS to present data on its first clinical trial using lentiviral vectors in a presentation entitled Findings from Phase I/II and decisions regarding next step. The presentation will address the following: — Successful delivery of a 937...
106 - Celera Corporation Fourth Quarter Calendar 2008 Results and Conference Call Scheduled for February 17, 2009
ALAMEDA, Calif.-(Business Wire)-January 22, 2009 - Celera Corporation (NASDAQ:CRA) announced today that it will issue fourth quarter calendar 2008 financial results on Tuesday, February 17, 2009. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy Ordoñez...
107 - Red Ribbon Charitable Foundation to Support AHF’s HIV/AIDS Services in Rural Florida
FT. LAUDERDALE, Fla.-(Business Wire)-January 22, 2009 - AIDS Healthcare Foundation (AHF), operator of Positive Healthcare Florida, is pleased to announce it has received a generous grant in the amount of $15,000 from Pensacola’s Red Ribbon Charitable Foundation, Inc. in support of the Positive...
108 - The Royal Government of Cambodia Awards the ‘Royal Order of Sahametrei’ to Dr. Chinkholal Thangsing
PHNOM PENH, Cambodia-(Business Wire)-January 22, 2009 - The Royal Government of Cambodia has awarded its prestigious “Royal Order of Sahametrei” to Dr. Chinkholal Thangsing, Asia Pacific Bureau Chief of AIDS Healthcare Foundation. The ‘Royal Order of Sahametrei’ is a medal of honour...
109 - Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics
SAN MARINO, Calif.-(Business Wire)-January 21, 2009 - Dr. Leslie Z. Benet, an internationally recognized drug development expert and one of the most highly cited pharmacologists in the world, has joined the advisors of Viral Genetics. CEO, Viral Genetics, Haig Keledjian said: “To have an advisor...
110 - Panacos Announces Sale of Bevirimat
WATERTOWN, Mass.-(Business Wire)-January 21, 2009 - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Myriad Pharmaceuticals, Inc. has acquired Panacos' rights and assets with...
111 - House Adopts AHF Stimulus Funding Proposal for HIV Testing and Prevention
WASHINGTON-(Business Wire)-January 17, 2009 - AIDS Healthcare Foundation (AHF) lauded the United States House of Representatives today for adopting AHF’s proposal to appropriate $300 million in the pending economic stimulus legislation and dedicate it for HIV/AIDS prevention, testing and services...
112 - Aussie Jessie Sparks Becomes a MAC Girl
LOS ANGELES-(Business Wire)-January 16, 2009 - Since winning a Hollywood Music Award for “Best Adult Contemporary Artist”, Melbourne Australia’s singer-songwriter Jessie Sparks’ (www.JessieSparks.com) career has been in high drive. MAC Cosmetics (www.maccosmetics.com) has officially...
113 - Monogram Announces Record Revenue for 2008, Guidance for Revenue Growth in 2009 and Plan for Achieving Sustainable Positive Cash Flow
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-January 15, 2009 - Monogram Biosciences, Inc. (Nasdaq:MGRM) announced that it expects to report revenues of approximately $62 million for the year ended December 31, 2008, an increase of 44% over the prior year. The company established 2009 revenue...
114 - ViraCor Laboratories Launches Fastest Available Cytomegalovirus Antiviral Resistance Test
KANSAS CITY, Mo.-(Business Wire)-January 15, 2009 - ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new cytomegalovirus (CMV) antiviral resistance test that provides diagnosis days faster than other tests on the market...
115 - BioAlliance Pharma Publishes Its 2009 Financial Calendar
PARIS-(Business Wire)-January 15, 2009 - Regulatory News: BioAlliance Pharma SA (Paris:BIO) has announced its financial calendar for 2009, which notably includes the publication dates for its revenue statements and half-year & annual accounts, as well as the date of its shareholders' Annual...
116 - Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
COLUMBIA, Md.-(Business Wire)-January 15, 2009 - Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced U.S. Food and Drug Administration (FDA) clearance to broaden its expanded access program (EAP) for Prochymal, now making the investigational stem cell product available to adults with...
117 - Room & Board Announces Two-Year Grant of $50,000 and Employee Time to Chicago House
MINNEAPOLIS-(Business Wire)-January 15, 2009 - Room & Board, the Minneapolis-based furniture retailer offering unique home furnishings that combine classic, simple design and exceptional quality, today announced a two-year gift totaling $50,000 and employee volunteer time to Chicago House, the...
118 - Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
COLUMBIA, Md.-(Business Wire)-January 15, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that it has held a successful pre-Biologics License Application (pre-BLA) meeting for Prochymal used in the treatment of graft-versus-host disease (GvHD). A BLA is a comprehensive regulatory...
119 - Aethlon Medical Nears Completion of First Medical Device Study to Treat HIV/AIDS
SAN DIEGO-(Business Wire)-January 15, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it is nearing completion of the “first-in-man” study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the...
120 - Immuron's BioGard HIV Antibody Into A U.S. Clinical Trial
SAN FRANCISCO & MELBOURNE, Australia-(Business Wire)-January 15, 2009 - Immuron Ltd. (ASX: IMC), a biopharmaceutical company specializing in oral immunotherapy development and antibody manufacturing, announced today approval for a Phase II human clinical study in HIV/AIDS patients at a...
121 - DSS, Inc. Invited to Speak at Sales Conference
JUNO BEACH, Fla.-(Business Wire)-January 14, 2009 - DSS, Inc. today announced that Jay Flejter, Vice President of Research and Development and Jeff Clarke, Consulting Engineer, were invited to speak at the Embarcadero Technologies Sales Kickoff meeting in San Francisco on January 12. According to...
122 - STD Rates: New Administration Must Revamp Prevention and Promote Safer Sex, Condom Usage, Says AHF
LOS ANGELES-(Business Wire)-January 14, 2009 - Alarming new statistics from the Centers for Disease Control (CDC) regarding sexually transmitted disease rates in the US show a steep jump in many STDs including Gonorrhea, syphilis and chlamydia, particularly among minority and youth populations...
123 - ‘Intent to Award’ Florida Medicaid HIV/AIDS Disease Management Program Notice Goes to AHF’s Positive Healthcare
FT. LAUDERDALE, Fla.-(Business Wire)-January 13, 2009 - Following a competitive bid process among three potential finalists, Florida’s Agency for Health Care Administration (AHCA) today issued an ‘intent to award’ notice regarding its ten year old Florida Medicaid HIV/AIDS Disease Management...
124 - Stimulus: Florida AIDS Patients, RNs Lobby Congress for Funding for HIV Testing
WASHINGTON-(Business Wire)-January 12, 2009 - As the HIV/AIDS epidemic continues to have a disproportionate—and devastating—impact throughout the Southern United States, a group of AIDS patients, nurses and medical providers from Florida are visiting Washington, DC this week for a series of...
125 - Ardea Biosciences Announces Positive Results from a Phase 1 Study of RDEA594
SAN DIEGO-(Business Wire)-January 12, 2009 - Ardea Biosciences, Inc. (Nasdaq:RDEA) today announced positive results from a completed single ascending dose (SAD) Phase 1 clinical study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. The study was conducted in...
126 - Illumina Genome Analyzer Selected by Internationally Recognized Medical Center to Sequence 50 Human Genomes
SAN DIEGO-(Business Wire)-January 12, 2009 - Illumina (NASDAQ:ILMN) today announced that researchers at Duke University Medical Center will utilize Illumina’s Genome Analyzer to study the resistance to HIV infection among 50 individuals that were highly exposed to the virus, but who remain...
127 - AHF: Just Say “No!” to Flynt’s Porn Industry Bailout Request
LOS ANGELES-(Business Wire)-January 11, 2009 - Larry Flynt is asking the taxpayers of this country to pay for his reckless, greed driven sexual exploitation of his "actors" and by extension, the public's lives. Flynt, the Porn King of America, is Public Health Enemy Number One regarding HIV/AIDS...
128 - Company Receives Grant to Further Develop Disease-Fighting Technology
WEST LAFAYETTE, Ind.-(Business Wire)-January 9, 2009 - Kylin Therapeutics announces plans to further develop a Purdue University technology that could allow physicians to target drug delivery for treatment of diseases ranging from AIDS to cancer. The life sciences firm received a $1.2 million...
129 - Osiris Therapeutics Receives $5 Million Milestone Payment
COLUMBIA, Md.-(Business Wire)-January 8, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that the company has received a $5 million milestone payment for reaching the first production threshold of the Osteocel supply agreement with NuVasive. In July of 2008, Osiris announced the...
130 - Celera to Webcast Presentation at JPMorgan Healthcare Conference
ALAMEDA, Calif.-(Business Wire)-January 7, 2009 - Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the 27th JPMorgan Annual Healthcare Conference on Wednesday, January 14, 2009. The presentation is scheduled to begin at 3:00 p.m. PT (6:00 p.m. ET), when...
131 - LabCorp To Present at the Goldman Sachs Healthcare Conference – Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance
BURLINGTON, N.C.-(Business Wire)-January 6, 2009 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Healthcare Conference in New York City, NY. LabCorp’s presentation is...
132 - ZymoGenetics to Webcast Presentation at J.P. Morgan Healthcare Conference
SEATTLE-(Business Wire)-January 6, 2009 - ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday...
133 - Incyte to Present at the 27th Annual JPMorgan Healthcare Conference
WILMINGTON, Del.-(Business Wire)-January 5, 2009 - Incyte Corporation (Nasdaq:INCY) announced today it will present at the 27th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009 at 3:30 p.m. (Pacific Time) / 6:30 p.m. (Eastern Time). Paul Friedman, M.D., president and chief...
134 - OraSure Technologies to Participate at the Eleventh Annual Needham Growth Conference
BETHLEHEM, Pa.-(Business Wire)-January 5, 2009 - OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Eleventh Annual Needham Growth Conference in New York at approximately 10:30 am...
135 - Avexa and Progen Merger Update
MELBOURNE, Australia-(Business Wire)-January 5, 2009 - Biotechnology companies Avexa Limited (ASX:AVX) and Progen Pharmaceuticals Limited (ASX:PGL) (NASDAQ:PGLA) announced an update to shareholders regarding their proposed merger. The companies will be hosting a series of investor forums to...
136 - "Homophobe" Rick Warren Seeks Redemption at AHF’s "Out of the Closet," Says AHF
LOS ANGELES-(Business Wire)-December 23, 2008 - AIDS Healthcare Foundation: What: Press Teleconference Call AHF, owner of “Out of the Closet” reacts to West Hollywood visit by Rick Warren When: TODAY Tuesday, December 23rd 2:30 pm Pacific Time Who: Michael Weinstein, President, AIDS...
137 - Court Orders Schwarzenegger Administration to Enforce HIV/AIDS Law, Says AHF
LOS ANGELES-(Business Wire)-December 23, 2008 - The Superior Court of California, County of Los Angeles has entered a judgment and will issue a writ ordering California’s Department of Health Care Services (DHCS) to implement a landmark 2002 law intended to extend Medi-Cal (Medicaid) coverage to...
138 - Napo Pharmaceuticals Announces Publication of Paper on Crofelemer for Indication of Irritable Bowel Syndrome
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-December 23, 2008 - Napo Pharmaceuticals, Inc., (“Napo”) announces that a paper entitled “Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients” (D-IBS) has been published in the Digestion...
139 - CytoDyn Launches Feasibility Study in China
SANTA FE, N.M.-(Business Wire)-December 19, 2008 - After meeting with representatives of the Xishan Economic Development Zone in Albuquerque, New Mexico, CytoDyn, Inc. (Pink Sheets: CYDY) has committed to a feasibility study in the People’s Republic of China. Dr. Feng Zhou, a Company consultant...
140 - AIDS Nobel Laureate Joins Viral Genetics
SAN MARINO, Calif.-(Business Wire)-December 18, 2008 - Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics (OTCBB: VRAL), a biotechnology company that discovers and develops immune-based therapies. Montagnier joins a...
141 - Ardea Biosciences Announces $30.6 Million Private Placement
SAN DIEGO-(Business Wire)-December 18, 2008 - Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that it has entered into a securities purchase agreement with certain institutional investors to raise approximately $30.6 million from the private placement of 2,737,336 newly issued shares of its...
142 - Researchers Successfully Used the 454 Sequencing System for Sensitive Detection of HIV Tropism
BRANFORD, Conn.-(Business Wire)-December 18, 2008 - 454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV...
143 - Starbucks and (RED) Debut the (STARBUCKS)RED Card to Help Save Lives in Africa
SEATTLE-(Business Wire)-December 18, 2008 - Starbucks Coffee Company (Nasdaq: SBUX) announced today that beginning January 3, customers will have the opportunity to make their purchase at Starbucks stores (RED) when they use the new (STARBUCKS)RED Card, a stored value Card that can be given as a...
Search Our News Using Google Search
Can't find what you want? Try using Google:
